January 6, 2017 / 10:20 PM / 7 months ago

BRIEF-Arena Pharmaceuticals says working to obtain data from its Phase 2 trial on etrasimod by end of 2017

1 Min Read

Jan 6 (Reuters) - Arena Pharmaceuticals Inc

* Says working diligently to obtain data from its Phase 2 trial on etrasimod for ulcerative colitis by end of 2017

* Arena Pharmaceuticals says assessing potential changes to trial protocol that it believes would improve data readout and enhance overall efficiency of trial

* Arena Pharmaceuticals says potential changes to trial protocol to also lower costs

* Arena Pharmaceuticals says intends to explore development in additional indications including dermatological extra-intestinal manifestations in IBD

* Arena Pharmaceuticals says it is designing exploratory phase ii clinical trials for each of the additional indications

* Says intend to initiate the Phase II trials on additional indications during 2017 Source text: (bit.ly/2iNlNd6) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below